Literature DB >> 10912491

Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group.

M L Petroni1, R P Jazrawi, P Pazzi, M Zuin, A Lanzini, M Fracchia, D Facchinetti, V Alvisi, R Ferraris, J M Bland, K W Heaton, M Podda, T C Northfield.   

Abstract

OBJECTIVE: To assess risk factors for gallstone recurrence following non-surgical treatment.
DESIGN: A prospective follow-up of a multicentre cohort of post-dissolution gallstone patients.
SETTING: Six gastroenterology units in the UK and Italy. PARTICIPANTS: One hundred and sixty-three patients with confirmed gallstone dissolution following non-surgical therapy (bile acids or lithotripsy plus bile acids), followed up by ultrasound scan and clinical assessment at 6-monthly intervals for up to 6 years (median, 25 months; range, 6-70 months). OUTCOME MEASURES: Subject-related variables (sex, age, height, weight, body mass index), gallstone-related variables (number, diameter, presence of symptoms, months to complete stone clearance), treatment modalities (bile acid therapy, extracorporeal shock wave lithotripsy) and follow-up related variables (weight change, use of non-steroidal anti-inflammatory agents, statins, pregnancies and/or use of oestrogens) were assessed by univariate and multivariate analysis as putative risk factors for gallstone recurrence.
RESULTS: Forty-five gallstone recurrences were observed during the follow-up period. Multiple primary gallstones and length of time to achieve gallstone dissolution were the only variables associated with a significant increase in the recurrence rate. Appearance of biliary sludge during follow-up was also significantly related to development of gallstone recurrence. Use of statins or non-steroidal anti-inflammatory agents did not confer protection against recurrence.
CONCLUSIONS: Patients with primary single stones are the best candidates for non-surgical treatment of gallstones, because of a low risk of gallstone recurrence. The positive association of recurrence with biliary sludge formation and time to dissolution of primary stones may provide indirect confirmation for the role of impaired gallbladder motility in the pathogenesis of this condition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10912491     DOI: 10.1097/00042737-200012060-00020

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

Review 1.  Targets for current pharmacologic therapy in cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa
Journal:  Gastroenterol Clin North Am       Date:  2010-06       Impact factor: 3.806

2.  Evaluating the controversial role of cholecystostomy in current clinical practice.

Authors:  Jonathan M Lorenz
Journal:  Semin Intervent Radiol       Date:  2011-12       Impact factor: 1.513

Review 3.  Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.

Authors:  Alan F Hofmann; Lee R Hagey
Journal:  J Lipid Res       Date:  2014-05-17       Impact factor: 5.922

4.  Therapy of gallstone disease: What it was, what it is, what it will be.

Authors:  Piero Portincasa; Agostino Di Ciaula; Leonilde Bonfrate; David Qh Wang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-04-06

5.  Risk factors for gallbladder contractility after cholecystolithotomy in elderly high-risk surgical patients.

Authors:  Tao Wang; Hao Luo; Hong-Tao Yan; Guo-Hu Zhang; Wei-Hui Liu; Li-Jun Tang
Journal:  Clin Interv Aging       Date:  2017-01-12       Impact factor: 4.458

Review 6.  Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family Physicians.

Authors:  Piero Portincasa; Agostino Di Ciaula; Ignazio Grattagliano
Journal:  Korean J Fam Med       Date:  2016-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.